[go: up one dir, main page]

GB997043A - Derivatives of 1,5-diarylpyrrole-2-propionic acid - Google Patents

Derivatives of 1,5-diarylpyrrole-2-propionic acid

Info

Publication number
GB997043A
GB997043A GB23682/63A GB2368263A GB997043A GB 997043 A GB997043 A GB 997043A GB 23682/63 A GB23682/63 A GB 23682/63A GB 2368263 A GB2368263 A GB 2368263A GB 997043 A GB997043 A GB 997043A
Authority
GB
United Kingdom
Prior art keywords
formula
lower alkyl
alkyl esters
salts
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB23682/63A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of GB997043A publication Critical patent/GB997043A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)

Abstract

The invention comprises compounds of formula <FORM:0997043/C2/1> wherein R is hydrogen or C1-C9 hydrocarbon acyl radical, Ar is alpha-naphthyl, tolyl, xylyl, o-methoxyphenyl, o-methylthiophenyl, or a substituted phenyl radical of formula <FORM:0997043/C2/2> where X is halogen or methyl and Y is hydrogen, halogen or methyl, and carboxylate salts and lower alkyl esters thereof, and the preparation of the above compounds by reaction of a carboxylic compound of formula <FORM:0997043/C2/3> or salts or lower alkyl esters thereof with amines of formula ArNH2, wherein R and Ar have the above meanings, preferably by refluxing in an inert solvent in the presence of a strong acid catalyst. Salts mentioned are the sodium, potassium, calcium, ammonium, chlorine and ethanolamine salts. Free acids of the first formula above may be converted to lower alkyl esters or free phenols may be acylated as required. Lower alkyl esters and acylated derivatives may be hydrolysed to free acids and phenols respectively. The lower alkyl radicals contain up to 4 carbon atoms. The carboxylic compounds of the third general formula above are prepared by reaction of 2-furaldehyde with p-hydroxyacetophenone, the resulting 3 - (2 - furyl - 41 - hydroxyacrylophenone is hydrolized to form the desired free carboxylic acid which may be converted to an acylate or a salt as required. The invention also provides for pharmaceutical compositions having hypocholesterenic activity containing compounds of the first formula above and an inert carrier, for oral or parenteral administration.
GB23682/63A 1962-06-14 1963-06-13 Derivatives of 1,5-diarylpyrrole-2-propionic acid Expired GB997043A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20239162A 1962-06-14 1962-06-14

Publications (1)

Publication Number Publication Date
GB997043A true GB997043A (en) 1965-06-30

Family

ID=22749681

Family Applications (1)

Application Number Title Priority Date Filing Date
GB23682/63A Expired GB997043A (en) 1962-06-14 1963-06-13 Derivatives of 1,5-diarylpyrrole-2-propionic acid

Country Status (2)

Country Link
FR (2) FR2916M (en)
GB (1) GB997043A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470857B2 (en) 2008-08-15 2013-06-25 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US8642628B2 (en) 2008-08-15 2014-02-04 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase
US8673961B2 (en) 2008-08-15 2014-03-18 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470857B2 (en) 2008-08-15 2013-06-25 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US8642628B2 (en) 2008-08-15 2014-02-04 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase
US8673961B2 (en) 2008-08-15 2014-03-18 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US8686015B2 (en) 2008-08-15 2014-04-01 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US8691816B2 (en) 2008-08-15 2014-04-08 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US8846736B2 (en) 2008-08-15 2014-09-30 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US8957105B2 (en) 2008-08-15 2015-02-17 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US9029402B2 (en) 2008-08-15 2015-05-12 Nivalis Therapeutics, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase
US9138427B2 (en) 2008-08-15 2015-09-22 Nivalis Therapeutics, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US9180119B2 (en) 2008-08-15 2015-11-10 Nivalis Therapeutics, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US9498466B2 (en) 2008-08-15 2016-11-22 Nivalis Therapeutics, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
US9814700B2 (en) 2008-08-15 2017-11-14 Nivalis Therapeutics, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

Also Published As

Publication number Publication date
FR2898M (en) 1964-11-02
FR2916M (en) 1964-11-09

Similar Documents

Publication Publication Date Title
ES417306A1 (en) Piperidine stabilizers for polymers
ES394370A1 (en) Pharmacologically active 3-piperazinyl-carbonyloxy-2-pyridyl-isoindolin-1-ones
GB1207371A (en) Cyclopropane carboxylic acids and derivatives thereof having insecticidal properties
GB997043A (en) Derivatives of 1,5-diarylpyrrole-2-propionic acid
ES400824A1 (en) Amidinocarbamates
GB1029228A (en) A method of preparing new quaternary ammonium salts with disinfectant activity
GB1386664A (en) Aminothiophene-carboxylic acid esters and process for their preparation
GB998996A (en) Derivatives of 1,5-diarylpyrrole-2-propionic acid
ES438695A1 (en) A procedure for the preparation of prostate acid derivatives. (Machine-translation by Google Translate, not legally binding)
ES419739A1 (en) 2-aryl-amino-imidazoline-2 compounds
ES434405A1 (en) Procedure for the preparation of imidazole derivatives. (Machine-translation by Google Translate, not legally binding)
ES397453A1 (en) Imidazoline derivatives of benzonorbornane and tetrahydronaphthalene compounds
GB1388450A (en) Pyrazolylphenylalkylaminoalkyl-ketones
GB1061425A (en) New benzofuran derivatives and process for preparing the same
ES382564A1 (en) Procedure for the preparation of derivatives of dihydro-10,11 dibenzo (b, f) azepine. (Machine-translation by Google Translate, not legally binding)
ES446743A1 (en) Crystalline cephalosporin salts
ES364722A1 (en) Procedure for the preparation of new derivatives of paminoalquil-bencensulfonamida. (Machine-translation by Google Translate, not legally binding)
GB1358911A (en) Tetrahydropyridylmethyl carboxylic acid esters
ES440831A1 (en) Benzylaminoalkanoic acids process for their preparation and pharmaceutical compositions containing them
ES325387A1 (en) Procedure for preparing insatured carboxylic acids. (Machine-translation by Google Translate, not legally binding)
ES421973A1 (en) A procedure for the preparation of pharmaceutically acceptable salts of benzopyran-carboxylic acid derivatives. (Machine-translation by Google Translate, not legally binding)
GB1082184A (en) Thiamine derivatives
GB1413255A (en) Acyloxyalkylpyrrolidine derivatives
GB1032377A (en) Asymmetrical pyridoxolyl disulphides and their preparation
GB1046258A (en) New 4-carboxyalkylmercapto-5-aryl pyrimidines and a method for their preparation